Nutex Health, Inc.NUTX

Market cap
$16.7B
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Net income (loss)-383,393-1,623,895250,489-684,34283,809-7,432,241582,062----432,739,618
Depreciation and amortization--40,25063,250-----4,64813
Amortization of debt issuance costs----------50,354
Impairment of goodwill-111,026------3-398
Stock-based compensation expense------924,326450,05434189,581
Rescission of warrant exercise expense----------561,651
Deferred tax expense----------984,8105
Debt accretion expense----------2
(Gain) loss on lease termination--------25,174--
Non-cash lease expense----------64,143
Accounts receivable-------4,004-111,567-71,90074,880-56,622,133
Accounts receivable - related party-----------1,454,934
Inventories----------719,107
Prepaid expenses and other current assets267,596-74,428122,487-34,520-199,207119,96169,56445,28065,467161,1551
Accounts payable----------10
Accounts payable - related party-----------329,155
Accrued expenses and other current liabilities-----------1,311,865
Net cash from operating activities-659,136-518,687-183,151165,80544,907-274,223-714,623-4,040,578-1,475,075-6,703,53051
Acquisitions of property and equipment----------15
Cash acquired in reverse acquisition.----------13
Cash related to deconsolidation of Real Estates Entities----------2
Net cash from investing activities418,387417,7351,800-4,739--9,9902,050-748,196-60,9008-4,337,398
Proceeds from lines of credit----------3
Proceeds from notes payable----------815,881
Repayments of lines of credit----------72,055
Repayments of notes payable---------16,7657
Repayments of finance leases----------2
Recission of warrant exercise----------588,042
Proceeds from Warrant Exercises---------153,4244
Proceeds from Stock Options Exercised---------178,842644,974
Members' contributions----------5
Members' distributions----------51
Net cash from financing activities--19,127103,500-54,50051,277172,444711,5006497,47214-48,132,730
Net change in cash and cash equivalents---------15-1,863,020